CD40 and neoplasm: Furthermore, tumor nest expression of CD40 protein, another B cell marker, was shown to associate with worse OS in our cohort supporting the likelihood of these tumor-infiltrating B cells as being adverse in raising anti-tumor immunity in SCLC.